These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9867140)

  • 1. PET quantification of specific binding of carbon-11-nicotine in human brain.
    Muzic RF; Berridge MS; Friedland RP; Zhu N; Nelson AD
    J Nucl Med; 1998 Dec; 39(12):2048-54. PubMed ID: 9867140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.
    Sihver W; Fasth KJ; Ogren M; Lundqvist H; Bergström M; Watanabe Y; Långström B; Nordberg A
    Nucl Med Biol; 1999 Aug; 26(6):633-40. PubMed ID: 10587101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.
    Nybäck H; Halldin C; Ahlin A; Curvall M; Eriksson L
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):31-6. PubMed ID: 7862909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain.
    Lundqvist H; Nordberg A; Hartvig P; Långström B
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):238-46. PubMed ID: 9772029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.
    Bart J; Willemsen AT; Groen HJ; van der Graaf WT; Wegman TD; Vaalburg W; de Vries EG; Hendrikse NH
    Neuroimage; 2003 Nov; 20(3):1775-82. PubMed ID: 14642487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET.
    Halldin C; Någren K; Swahn CG; Långström B; Nybäck H
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):871-80. PubMed ID: 1428915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.
    Nordberg A; Hartvig P; Lundqvist H; Antoni G; Ulin J; Långström B
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):195-205. PubMed ID: 2789067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of 11C-(R)nicotine in human brain measured by positron emission tomography: measurement of cerebral blood flow.
    Hara T; Komiyama T; Yokoi F
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):175-81. PubMed ID: 8237133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.
    Nordberg A; Lundqvist H; Hartvig P; Lilja A; Långström B
    Alzheimer Dis Assoc Disord; 1995; 9(1):21-7. PubMed ID: 7605618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data.
    Logan J; Volkow ND; Fowler JS; Wang GJ; Dewey SL; MacGregor R; Schlyer D; Gatley SJ; Pappas N; King P
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):995-1010. PubMed ID: 7929663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.
    Nordberg A; Hartvig P; Lilja A; Viitanen M; Amberla K; Lundqvist H; Andersson Y; Ulin J; Winblad B; Långström B
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):215-24. PubMed ID: 2257061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of carbon-11 labelled nicotine in the measurement of human cerebral blood flow and other physiological parameters.
    Yokoi F; Komiyama T; Ito T; Hayashi T; Lio M; Hara T
    Eur J Nucl Med; 1993 Jan; 20(1):46-52. PubMed ID: 8420783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.
    Koeppe RA; Holthoff VA; Frey KA; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):735-44. PubMed ID: 1651944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.
    Koeppe RA; Frey KA; Mulholland GK; Kilbourn MR; Buck A; Lee KS; Kuhl DE
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):85-99. PubMed ID: 8263062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncompartmental and compartmental modeling of the kinetics of carbon-11 labeled pyrilamine in the human brain.
    Szabo Z; Ravert HT; Gözükara I; Geckle W; Seki C; Sostre S; Peller P; Monsein L; Natarajan TK; Links JM
    Synapse; 1993 Dec; 15(4):263-75. PubMed ID: 7908760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.
    Saji H; Magata Y; Yamada Y; Tajima K; Yonekura Y; Konishi J; Ohmomo Y; Yokoyama A
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):734-6. PubMed ID: 1611685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling alternatives for cerebral carbon-11-iomazenil kinetics.
    Buck A; Westera G; vonSchulthess GK; Burger C
    J Nucl Med; 1996 Apr; 37(4):699-705. PubMed ID: 8691270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for removing the bias in the graphical analysis method.
    Logan J; Fowler JS; Volkow ND; Ding YS; Wang GJ; Alexoff DL
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):307-20. PubMed ID: 11295885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.